Description
A sphingolipid; has been used as an internal standard for the quantification of globotriaosylceramides in plasma and urine from patients with Fabry disease by GC-MS
Formal name: N-[(1S,2R,3E)-1-[([O-α-D-galactopyranosyl-(1→4)-O-β-D-galactopyranosyl-(1→4)-β-D-glucopyranosyl]oxy)methyl]-2-hydroxy-3-heptadecenyl]-heptadecanamide
Synonyms: C17 Ceramide Trihexoside (d18:1/17:0)|N-Heptadecanoyl Ceramide Trihexoside
Molecular weight: 1,038.30
CAS: 536745-81-0
Purity: ≥98%
Formulation: A solid
Application|Mass Spectrometry||Product Type|Biochemicals|Analytical Standards||Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Lipid Biochemistry|Sphingolipids